Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial

Authors
Marzieh Akbarzadeh 1
Sanaz Zeinalzadeh 2
Jaleh Zolghadri 3
Abdolali Mohagheghzadeh 4
Pouya Faridi 4
Mehrab Sayadi 5
1 Community Based Psychiatric Care Research Center, Department of Midwifery, Fatemeh (P.B.U.H) School of Nursing and Midwifery, Shiraz University of Medical Sciences,, Shiraz, Iran
2 Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
4 Department of Traditional Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
5 Department of Bio-statistics, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: Orgasmic disorder can create a feeling of deprivation and failure and provide mental problems, incompatibility and marital discord. This study aimed to compare the effects of Elaeagnus angustifolia flower extract and sildenafil citrate on female orgasmic disorder in women in 2013. Methods: In this randomized clinical trial, 125 women between 18-40 years old who suffered from orgasmic disorder were divided into three E. angustifolia, sildenafil citrate and control groups. The data were gathered using Female Sexual Function Index and through measurement of TSH and prolactin. The first intervention group had to consume 4.5 gr E. angustifolia extract in two divided doses for 35 days and the second one had to use 50 mg sildenafil citrate tablets for 4 weeks one hour before their sexual relationship. However, the control group had to consume the placebo. The data were analyzed using paired t-test, one-way ANOVA, and Bonferroni post-hoc test and p<0.05 was considered significant. Results: The frequency of orgasmic disorder before the intervention was 41.5%, 40.5%, and 57.1% in E. angustifolia, sildenafil citrate, and control groups, respectively (p=0.23). However, these measures were respectively 29.3%, 16.7%, and 50% after the intervention (p=0.004). A significant difference between the two groups regarding sexual satisfaction after the intervention (p=0.003) compared to the beginning of the study (p=0.356). Besides, the highest reduction of changes after the intervention (58.82%) was observed in the sildenafil citrate group. Conclusion: Both E. angustifolia extract and sildenafil citrate were effective in reduction of the frequency of orgasmic disorder in women.
Keywords
Elaeagnus angustifolia
Orgasmic disorder
Sildenafil citrate
  1. Basson R. Women's sexual dysfunction: revised and expanded definitions. CMAJ. 2005;172(10):1327-33.
  2. Brezsnyak M, Whisman MA. Sexual desire and relationship functioning: the effects of marital satisfaction and power. J Sex Marital Ther. 2004;30(3):199-217.
  3. Zhang H, Yip PS. Female sexual dysfunction among young and middle-aged women in Hong Kong: prevalence and risk factors. J Sex Med. 2012;9(11):2911-8.
  4. Hassanin IM, Helmy YA, Fathalla MM, Shahin AY. Prevalence and characteristics of female sexual dysfunction in a sample of women from Upper Egypt. Int J Gynaecol Obstet. 2010;108(3):219-23.
  5. Arasteh M, Shams Alizadeh N, Ghaderi E, Farhadifar F, Nabati R, Gharibi F. Survey of the prevalence of sexual dysfunctions in Kurdish women. J Sex Marital Ther. 2014;40(6):503-11.
  6. Ghanbarzadeh N, Nadjafi-Semnani M, Ghanbarzadeh MR, Nadjfai-Semnani A, Nadjfai-Semnani F. Female sexual dysfunction in Iran: study of prevalence and risk factors. Arch Gynecol Obstet. 2013;287(3):533-9.
  7. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18(4):382-95.
  8. Basson R. Women's sexual function and dysfunction: current uncertainties, future directions. Int J Impot Res. 2008;20(5):466-78.
  9. Brown AD, Blagg J, Reynolds DS. Designing drugs for the treatment of female sexual dysfunction. Drug Discov Today. 2007;12(17-18):757-66.
  10. Goldstein I. Sexual dysfunction in women: what can urologists contribute? Curr Urol Rep. 2008;9(6):475-82.
  11. Allahdadi KJ, Tostes RC, Webb RC. Female sexual dysfunction: therapeutic options and experimental challenges. Cardiovasc Hematol Agents Med Chem. 2009;7(4):260-9.
  12. Bancroft J. The endocrinology of sexual arousal. J Endocrinol. 2005;186(3):411-27.
  13. Bancroft J. Sexual effects of androgens in women: some theoretical considerations. Fertil Steril. 2002;77 Suppl 4:S55-9.
  14. Davis SR. Androgens and female sexuality. J Gend Specif Med. 2000;3(1):36-40.
  15. Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther. 2001;27(5):411-20.
  16. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG. 2001;108(6):623-8.
  17. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11(4):367-77.
  18. Cavalcanti AL, Bagnoli VR, Fonseca AM, Pastore RA, Cardoso EB, Paixao JS, et al. Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction. Int J Gynaecol Obstet. 2008;102(2):115-9.
  19. D'Amati G, di Gioia CR, Bologna M, Giordano D, Giorgi M, Dolci S, et al. Type 5 phosphodiesterase expression in the human vagina. Urology. 2002;60(1):191-5.
  20. Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, et al. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 2006;67(5):1111-6.
  21. Uckert S, Ellinghaus P, Albrecht K, Jonas U, Oelke M. Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genitaltissues. J Sex Med. 2007;4(6):1604-9.
  22. Caruso S, Intelisano G, Farina M, Di Mari L, Agnello C. The function of sildenafil on female sexual pathways: a double-blind, cross-over, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2003;110(2):201-6.
  23. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomized controlled trial. BJOG. 2003;110(11):1014-24.
  24. Austin MP, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Aust N Z J Obstet Gynaecol. 2000;40(3):331-7.
  25. Morley JE, Kaiser FE. Female sexuality. Med Clin North Am. 2003;87(5):1077-90.
  26. Azaizeh H, Saad B, Cooper E, Said O. Traditional Arabic and Islamic Medicine, a Re-emerging Health Aid. Evid Based Complement Alternat Med. 2010;7(4):419-24.
  27. Saini NK, Singhal M, Srivastava B, Sharma S. Natural plants effective in treatment of sexual dysfunction: A Review. Pharma Res. 2010;4(2):206-24.
  28. Murphy LL, Lee TJ. Ginseng, sex behavior, and nitric oxide. Ann N Y Acad Sci. 2002;962(1):372-7.
  29. Rowland D, Tai W. A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. J Sex Marital Ther. 2003;29(3):185-205.
  30. Krychman ML, Gubili MS, Pereira L, Holstein L, Cassileth B. Female sexual enhancers and neutraceuticals. Curr Sex Health Rep. 2007;4(4):177-182.doi: 10.1007/s11930-007-0023-0
  31. Mehrabani Natanzi M, Pasalar P, Kamalinejad M, Dehpour AR, Tavangar SM, Sharifi R, et al. Effect of aqueous extract of Elaeagnus angustifolia fruit on experimental cutaneous wound healing in rats. Acta Med Iran. 2012;50(9):589-96.
  32. Iriondo JM, De La Iglesia M, Perez C. Micropropagation of Elaeagnus angustifolia from mature trees. Tree Physiol. 1995;15(10):691-3.
  33. Talaei-Khozani T, Vojdani Z, Dehghani F, Heidari E, Kharazinejad E, Panjehshahin MR. Toxic effects of Elaeagnus angustifolia fruit extract on chondrogenesis and osteogenesis in mouse limb buds. Tokai J Exp Clin Med. 2011;36(3):63-70.
  34. Mohammed FI, Al-Essa MK, Shafagoj YA, Afifi FU. Investigation of the direct effects of the alcoholic extract of Elaeagnus angustifolia L. (Elaeagnaceae) on dispersed intestinal smooth muscle cells of guinea pig. Sci Pharm. 2006;74:21-30.
  35. Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M, et al. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J Ethnopharmacol. 2000;72(1-2):287-92.
  36. Zargari A. [Herbal drugs]. 4th ed. Tehran: Tehran University; 2000. p. 274-77. Persian.
  37. Caliskan E, Elmastas M, Gokce I. Evaluation of antioxidant properties of Elaeagnus angustifolia flowers. Asian J Chem. 2010;22(4):2840-48.
  38. Bucur L, Stanciu G, Istudor V. The GC-MS analysis of Elaeagnus angustifolia L. flowers essential oil. Rev Chim. 2007;58(11):1027-29.
  39. Bucur L, Hirjau V, Istudor V. Elaeagnus angustifolia flower soft extract valorification in a dermatological preparation note 2. Farmacia. 2009;57(3):309-314.
  40. Hosseinzadeh H, Ramezani M, Namjo N. Muscle relaxant activity of Elaeagnus angustifolia L. fruit seeds in mice. J Ethnopharmacol. 2003;84(2-3):275-8.
  41. Ahmadiani A, Fereidoni M, Semnanian S, Kamalinejad M, Saremi S. Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats. J Ethnopharmacol. 1998;61(3):229-35.
  42. Ramezani M, Hosseinzadeh H, Daneshmand N. Antinociceptive effect of Elaeagnus angustifolia fruit seeds in mice. Fitoterapia. 2001;72(3):255-62.
  43. Izquierdo I, Pereira ME, Medina JH. Benzodiazepine receptor ligand influences on acquisition: suggestion of an endogenous modulatory mechanism mediated by benzodiazepine receptors. Behav Neural Biol. 1990;54(1):27-41.
  44. Marder M, Viola H, Wasowski C, Wolfman C, Waterman PG, Cassels BK, et al. 6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. Biochem Biophys Res Commun. 1996;223(2):384-9.
  45. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina JH. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997;58(4):887-91.
  46. Fakhri A, Pakpour AH, Burri A, Morshedi H, Zeidi IM. The Female Sexual Function Index: translation and validation of an Iranian version. J Sex Med. 2012;9(2):514-23.
  47. Rosen RC. Assessment of female sexual dysfunction: review of validated methods. Fertil Steril. 2002;77 Suppl 4:S89-93.
  48. Akhtari E, Raisi F, Keshavarz M, Hosseini H, Sohrabvand F, Bioos S, et al. Tribulus terrestris for treatment of sexual dysfunction in women: randomized double-blind placebo-controlled study. Daru. 2014;22(1):40.
  49. Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology. 2004;63(5):955-9.
  50. Dasgupta R, Wiseman OJ, Kanabar G, Fowler CJ, Mikol D. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol. 2004;171(3):1189-93.
  51. Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril. 2006;85(5):1496-501.
  52. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008;300(4):395-404.
  53. Wylie K, Malik F. Review of drug treatment for female sexual dysfunction. Int J STD AIDS. 2009;20(10):671-4.
  54. Basson R. Clinical practice. Sexual desire and aurosal disorders in women. N Engl J Med. 2006;354(14):1497-506.
  55. Waynberg J, Brewer S. Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women. Adv Ther. 2000;17(5):255-62.
  56. Ito TY, Polan ML, Whipple B, Trant AS. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status. J Sex Marital Ther. 2006;32(5):369-78.
  57. Amin Gh. Herbal medicine, the Iranian folkloric drugs. 1st ed. Tehran: Ministry of Health; 2001. p. 101-6.
  58. Dembinska-Migas W, Gill S. Flavonoids in leaves of Elaeagnus angustifolia L. Pol J Pharmacol Pharm. 1973;25(6):599-606.
  59. Goncharova NP, Plagar VN, Rashkes Y. Oxygenated fatty acids of seeds of Elaeagnus angustifolia. Chem Nat Compound. 1994;30(6):661-68.
  60. Muthiah NS, Vijayasekaran V. Anti inflammatory activity of flavone and its methoxy derivative: structure activity study. Indian J Pharm Sci. 1993;55(5):180-3.
  61. Kang DG, Choi DH, Lee JK, Lee YJ, Moon MK, Yang SN, et al. Endothelial NO/cGMP-dependent vascular relaxation of cornuside isolated from the fruit of Cornus officinalis. Planta Med. 2007;73(14):1436-40.
  62. Durand S, Davis SL, Cui J, Crandall CG. Exogenous nitric oxide inhibits. Sympathetically mediated vasoconstriction in human skin. J Physiol. 2005;562(Pt 2):629-34.
  63. Konishi M, Su C. Role of the endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 1983;5(6):881-6.
  64. Heuze-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren TJ. Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney. Eur J Pharmacol. 1992;220(2-3):161-71.
  65. Vincent SR. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol. 1994;42(1):129-60.
  66. Gray E, Ferrell WR. Acute joint in flammation alters the adrenoceptor profile of synovial blood vessels in the knee joint of rabbits. Ann Rheum Dis. 1992;51(10):1129-33.
  67. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39(3):163-96.
  68. Byers ES. Relationship satisfaction and sexual satisfaction: A longitudinal study of individuals in long-term relationships. J Sex Res. 2005;42(2):113-8.
  69. Litzinger S, Gordon KC. Exploring relationships among communication, sexual satisfaction, and marital satisfaction. J Sex Marital Ther. 2005;31(5):409-24.
  70. Polan ML, Hochberg RB, Trant AS, Wuh HC. Estrogen bioassay of ginseng extract and ArginMax, a nutritional supplement for the enhancement of female sexual function. J Womens Health (Larchmt). 2004;13(4):427-30.
  71. Kumar S, Sharma A. Anti-anxiety activity studies on homoeopathic formulations of turnera aphrodisiaca ward. Evid Based Complement Alternat Med. 2005;2(1):117-119.
Journal of Reproduction & Infertility
Volume 15, Issue 4
Autumn 2014
Pages 190-198